Crop protection and seed provider Corteva Agriscience, Wilmington, Del., and biostimulant developer Dadelos Agrosolutions SL, Valencia, Spain, an affiliate of Ajinomoto Co. Inc., Tokyo, on Feb. 11 announced an agreement to develop, validate, and commercialize biostimulants for farmers around the globe.
Corteva recently created a global biologicals portfolio dedicated to developing biostimulants, biocontrol, and pheromone products to work side-by-side with conventional crop protection solutions.
“This agreement furthers our commitment to offering farmers biologicals for crop protection, including a complete line of biostimulant solutions based on demonstrated effects and predictable results,” said Rajan Gajaria, Executive Vice President, Business Platforms, Corteva Agriscience. “Our agreement with Dadelos Agrosolutions is another step in demonstrating our efforts to building our biological portfolio by collaborating with the leading experts in their fields.”
“The technologies and crop solutions that we have been developing for the last 24 years aim to help the industry and the farmers to produce more food of better quality while reducing impact on the environment,” said Norbert Pons, CEO of Dadelos Agrosolutions.
“Our mission is a clear example of the Ajinomoto Group Creating Shared Value (ASV) and the philosophy of Ajinomoto to consistently engage in initiatives to solve social issues through business,” Pons added. “This agreement with Corteva Agriscience confirms the interest of our collaborators and clients for our science- based solutions, our capacity to innovate and our continuous efforts to constantly create added value for our customers around the world.”
Further details of the agreement were not disclosed.
Publicly traded Corteva Agriscience became an independent company on June 1, 2019 and was previously the Agriculture Division of DowDuPont.
Ajinomoto, a major food and biotechnology company, has offices in 35 countries and regions and sells products in more than 130 countries and regions. In fiscal 2019, sales were $10.1 billion.